Literature DB >> 11641787

Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.

P N Tonin1, T J Hudson, F Rodier, M Bossolasco, P D Lee, J Novak, E N Manderson, D Provencher, A M Mes-Masson.   

Abstract

We have previously described an ovarian cancer model based on four independent spontaneously immortalized epithelial ovarian cancer cell lines (TOV-21G, TOV-81D, TOV-112D and OV-90) from patients who were never exposed to chemotherapy or radiation therapy. These cell lines are particularly interesting since they retain characteristics of the original epithelial ovarian cancers (EOC) from which they were derived. Here we report the characterization of this model system using high-density DNA microarrays in order to assess gene expression. Expression profiles were generated from total RNAs extracted from the four EOC cell lines. For comparison, expression profiling is also provided for a primary culture of normal ovarian surface epithelium (NOV-31) and a fresh EOC sample (TOV-578G). Comparison of expression profiles revealed patterns of expression that distinguish NOV-31 from that of all tumor derived samples. The expression pattern of TOV-81D, an EOC cell line that was derived from a patient with indolent disease, most closely resembles NOV-31 while profiles of samples derived from patients with more aggressive disease (TOV-21G, OV-90, TOV-112D and TOV-578G) showed more divergent patterns of expression. The microarray analysis (http://genome.mcgill.ca) results confirm the usefulness of an ovarian cancer model based on the characterization of these EOC cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641787     DOI: 10.1038/sj.onc.1204804

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

Authors:  Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity.

Authors:  Isabel López de Silanes; Jinshui Fan; Craig J Galbán; Richard G Spencer; Kevin G Becker; Myriam Gorospe
Journal:  Gene Expr       Date:  2004

3.  Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model.

Authors:  Liliane Meunier; Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Mario Chevrette; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

4.  Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.

Authors:  Jean-Philippe Gagné; Pierre Gagné; Joanna M Hunter; Marie-Eve Bonicalzi; Jean-François Lemay; Isabelle Kelly; Cécile Le Page; Diane Provencher; Anne-Marie Mes-Masson; Amaud Droit; David Bourgais; Guy G Poirier
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.

Authors:  Lan Dai; Chen Li; Kerby A Shedden; David E Misek; David M Lubman
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

6.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.

Authors:  Fengkun Du; Yan Li; Wensheng Zhang; Shubha P Kale; Harris McFerrin; Ian Davenport; Guangdi Wang; Elena Skripnikova; Xiao-Lin Li; Nathan J Bowen; Leticia B McDaniels; Yuan-Xiang Meng; Paula Polk; Yong-Yu Liu; Qian-Jin Zhang
Journal:  Tumour Biol       Date:  2016-03-02

8.  Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Authors:  Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

9.  Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.

Authors:  Ingrid Moen; Matthew Gebre; Vanesa Alonso-Camino; Debbie Chen; David Epstein; Donald M McDonald
Journal:  Clin Exp Metastasis       Date:  2015-10-07       Impact factor: 5.150

10.  The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profiles.

Authors:  Michael C J Quinn; Daniel J Wilson; Fiona Young; Adam A Dempsey; Suzanna L Arcand; Ashley H Birch; Paulina M Wojnarowicz; Diane Provencher; Anne-Marie Mes-Masson; David Englert; Patricia N Tonin
Journal:  J Transl Med       Date:  2009-07-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.